• Low-tech/outsource service businesses
• Stable and consistent revenue and earnings stream
• Diverse customer base with a mix of bio-tech, big and small pharma and med-tech clients
• Reputation for consistent quality and compliance
• Consolidation opportunity - opportunity to add complementary products and services

Industry Description
The life sciences industry includes vendors and service providers that support research and development for drug and device production.

Value Proposition
Drug and device developers increasingly outsource many functional elements of their businesses, including clinical trial operations and manufacturing, to focus on their core competencies. Emerging device, biotechnology, and small drug companies have surpassed pharmaceutical companies as the primary source of new medicines. Life sciences service providers offer the expertise, scale, and efficiencies to support the growth and improved profitability that developers of medical technology and compounds demand.

Growth Characteristics
Global biopharmaceutical research and development is expected to increase seven percent annually, reaching $107 billion by 2010. The overall demand for support and outsourced services will be driven by increased development efforts by pharmaceutical companies to replenish their drug pipelines, emerging device, biotech, and specialty pharmaceutical companies with limited infrastructure and funding, and the general trend toward outsourcing non-core functions.

Segments of Interest
Contract research organizations, contract manufacturers and packagers, diagnostics, and consumable laboratory equipment and materials. INDUSTRIES QUICK LINKS
Healthcare
Life Sciences
Business Services
Education and Training
Financial Services
Infrastructure / Energy Services

EXCELLERE PARTNERS

100 Fillmore Place, Suite 300 | Denver, CO 80206 | 303.765.2400 | 303.765.2411 Fax